| Literature DB >> 30405715 |
Michelle Griffin1,2,3, Naghmeh Naderi1,3,4,5, Deepak M Kalaskar1, Edward Malins6, Remzi Becer6, Catherine A Thornton4, Iain S Whitaker4,5, Ash Mosahebi3, Peter E M Butler1,2,3, Alexander M Seifalian7.
Abstract
An effective sterilisation technique that maintains structure integrity, mechanical properties, and biocompatibility is essential for the translation of new biomaterials to the clinical setting. We aimed to establish an effective sterilisation technique for a biodegradable (POSS-PCL) and nonbiodegradable (POSS-PCU) nanocomposite scaffold that maintains stem cell biocompatibility. Scaffolds were sterilised using 70% ethanol, ultraviolet radiation, bleach, antibiotic/antimycotic, ethylene oxide, gamma irradiation, argon plasma, or autoclaving. Samples were immersed in tryptone soya broth and thioglycollate medium and inspected for signs of microbial growth. Scaffold surface and mechanical and molecular weight properties were investigated. AlamarBlue viability assay of adipose derived stem cells (ADSC) seeded on scaffolds was performed to investigate metabolic activity. Confocal imaging of rhodamine phalloidin and DAPI stained ADSCs was performed to evaluate morphology. Ethylene oxide, gamma irradiation, argon plasma, autoclaving, 70% ethanol, and bleach were effective in sterilising the scaffolds. Autoclaving, gamma irradiation, and ethylene oxide led to a significant change in the molecular weight distribution of POSS-PCL and gamma irradiation and ethylene oxide to that of POSS-PCU (p<0.05). UV, ethanol, gamma irradiation, and ethylene oxide caused significant changes in the mechanical properties of POSS-PCL (p<0.05). Argon was associated with significantly higher surface wettability and ADSC metabolic activity (p<0.05). In this study, argon plasma was an effective sterilisation technique for both nonbiodegradable and biodegradable nanocomposite scaffolds. Argon plasma should be further investigated as a potential sterilisation technique for medical devices.Entities:
Year: 2018 PMID: 30405715 PMCID: PMC6192142 DOI: 10.1155/2018/6565783
Source DB: PubMed Journal: Int J Biomater ISSN: 1687-8787
Mechanical Properties of POSS-PCU and POSS-PCL after sterilisation processes. Young's modulus, maximum stress, elongation at break, and thickness of control POSS-PCL and POSS-PCU and samples subjected to ethanol, bleach (SDIC), plasma, ethylene oxide, UV radiation, antibiotic/antimycotic treatment, and gamma irradiation.
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
| Young's Modulus (MPa) | POSS-PCL | 0.18 ± 0.0 | 0.29 ± 0.02 | 0.20 ± 0.02 | 0.32 ± 0.04 | 0.40 ± 0.11 | 0.35 ± 0.02 | 0.25 ± 0.03 | 0.30 ± 0.05 | N/A |
| POSS-PCU | 0.55 ± 0.04 | 0.57 ± 0.02 | 0.56 ± 0.02 | 0.56 ± 0.04 | 0.55 ± 0.02 | 0.55 ± 0.02 | 0.53 ± 0.01 | 0.55 ± 0.03 | 0.54 ± 0.02 | |
| Maximum Stress (MPa) | POSS-PCL | 0.56 ± 0.08 | 0.61 ± 0.10 | 0.31 ± 0.11 | 1.17 ± 0.15 | 1.71 ± 0.19 | 1.45 ± 0.04 | 1.10 ± 0.14 | 0.80 ± 0.26 | N/A |
| POSS-PCU | 0.83 ± 0.03 | 0.82 ± 0.06 | 0.85 ± 0.03 | 0.83 ± 0.01 | 0.84 ± 0.01 | 0.83 ± 0.01 | 0.81 ± 0.12 | 0.83 ± 0.02 | 0.82 ± 0.04 | |
| Elongation at break (%) | POSS-PCL | 589.6 ± 26.2 | 549.7 ± 68 | 293.0 ± 61 | 462.2 ± 16 | 471.6 ± 39 | 387.5 ± 22 | 469.5 ± 11 | 500.1 ± 30 | N/A |
| POSS-PCU | 283.3 ± 9.57 | 273.6 ± 10.01 | 279.2 ± 1.74 | 288.0 ± 3.05 | 288.6 ± 1.46 | 269.3 ± 8.55 | 273.8 ± 9.01 | 281.1 ± 4.12 | 280.5 ± 7.88 | |
| Thickness (mm) | POSS-PCL | 2.0 ± 0 | 1.43 ± 0.15 | 1.525 ± 0.13 | 1.6 ± 0.22 | 1.2 ± 0.25 | 1.38 ± 0.05 | 1.55 ± 0.17 | 2.433 ± 0.12 | N/A |
| POSS-PCU | 0.75 ± 0.04 | 0.77 ± 0.02 | 0.84 ± 0.02 | 0.77 ± 0.05 | 0.76 ± 0.02 | 0.77 ± 0.02 | 0.75 ± 0.03 | 0.76 ± 0.02 | 0.74 ± 0.06 | |
Figure 1Contact angles of POSS-PCL and POSS-PCU samples measured after different sterilisation techniques. One-way ANOVA and Turkey's multiple comparison test was used to show statistical significance. ∗ indicates statistically significant differences (∗p < 0.05 and ∗∗∗p < 0.001).
Figure 2POSS-PCL and POSS-PCU FTIR spectra after different sterilisation techniques. [a] SDIC treatment led to a slight decrease in the peaks at 1634 cm−1 and 1557 cm−1 and an increase in the peak at 1520 cm−1 compared to untreated control POSS-PCL. [b] No major changes were noted in the FTIR spectra of POSS-PCU samples after different sterilisation methods.
Summary of gel permeation chromatography (GPC) results. Molecular weight (Mw) and molecular number (Mn) values of POSS-PCL and POSS-PCU after different sterilisation techniques.
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
| Mass-average Molecular Weight (Mw) (g/mol) | POSS-PCL | 361100 | 350900 | 356100 | 276300 | 151200 | 358600 | 391600 | 174600 | 365400 |
| POSS-PCU | 91200 | 92000 | 89400 | 112200 | 135000 | 90800 | 92700 | 88300 | 93800 | |
| Number-average Molecular Weight (Mn) (g/mol) | POSS-PCL | 141000 | 137600 | 111300 | 97500 | 44700 | 113300 | 160800 | 88100 | 155300 |
| POSS-PCU | 47700 | 46300 | 47200 | 34200 | 40000 | 46700 | 46200 | 45500 | 46200 |
Figure 3Scanning electron microscopy (SEM) images of POSS-PCL (left) and POSS-PCU (right) surfaces after different sterilisation techniques.
Figure 4AlamarBlue viability assay of adipose derived stem cells (ADSCs) after 1, 3, 7, 10, and 14 days of incubation on (a) POSS-PCL and (b) POSS-PCU samples. Statistical significance was shown using two-way ANOVA and Turkey's multiple comparisons test. ∗ indicates statistically significant differences (∗p < 0.05).
Figure 5Summary of POSS-PCL and POSS-PCU sterilisation efficacy for bleach (SDIC), ethanol, ethylene oxide, gamma, plasma, antibiotic/antimycotic, UV, and autoclaving sterilisation techniques. All control samples (3) of POSS-PCU and POSS-PCL and 1 of 9 POSS-PCL samples sterilised using UV and antibiotic/antimycotic were infected.
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
| POSS-PCL | TSB | 9/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 1/9 | 1/9 | N/A |
| THY | 9/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 1/9 | 1/9 | N/A | |
| POSS-PCU | TSB | 9/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 |
| THY | 9/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | 0/9 | |